Our scaffold is cross-linked collagen (DNA free). There's a lot involved. Moulding; cell infiltration; blood supply; mimicking the function of the synoatrial node; a big f@#king lightning bolt connected to a machine with the patient on it......
That said I believe we will see Adapt 2.0 at some point in the future, and this is where the synergy lies between AHZ, CYP & a third party who has an MSC trial for any number of heart conditions. We provide the DNA free scaffold, they provide the allogenic MSCs, Bam! Adapt 2.0.
Here is something to keep you interested:
http://www.dailymail.co.uk/health/a...cells-grow-BEATING-human-heart-time-ever.html
W
Schwarzenegger has valve replacement by catheter., page-64
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.20 |
Change
-0.550(3.10%) |
Mkt cap ! $330.6M | |||
| Open | High | Low | Value | Volume |
| $17.75 | $17.75 | $16.88 | $199.1K | 11.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $17.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.24 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |